本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

6.43
-0.1100-1.68%
盘后6.480.0493+0.77%17:13 EDT
成交量:4,164.38万
成交额:2.74亿
市值:27.91亿
市盈率:-3.53
高:7.14
开:6.70
低:6.28
收:6.54
数据加载中...
2025/01/10

关联方拟减持公告

Form 144 | RECURSION PHARMACEUTICALS高管 Christopher拟减持20000股,总价约141,000美元
2025/01/08

关联方拟减持公告

Form 144 | Recursion Pharmaceuticals, Inc. 高管 Gibson 拟减持2万股,总价约14.62万美元
2024/12/26

关联方拟减持公告

Form 144 | Recursion Pharmaceuticals 高管 Tina Marriott 拟减持6000股,总价约4.48万美元
2024/12/17

重要事件披露

Form 8-K - Current report
2024/12/11

关联方拟减持公告

Form 144 | RECURSION PHARMACEUTICALS高管Michael Secora拟减持15000股,总价约11.22万美元
2024/12/10

关联方拟减持公告

Form 144 | Recursion Pharmaceuticals 高管 Michael Secora 拟减持15000股,总价约11.63万美元
2024/12/05

关联方拟减持公告

Form 144 | Recursion Pharmaceuticals高管Gibson Christopher拟减持20,000股,总价约14.24万美元
2024/12/04

关联方拟减持公告

Form 144 | RECURSION PHARMACEUTICALS, INC. 高管 Gibson Christopher 拟减持20000股,总价约14.32万美元
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/27

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/11/26

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities